Quidel Corporation (QDEL) financial statements (2021 and earlier)

Company profile

Business Address 9975 SUMMERS RIDGE ROAD
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments490534436170191201
Cash and cash equivalents490534436170191201
Restricted cash and investments     03
Receivables394836167251834
Inventory, net of allowances, customer advances and progress billings114586767262625
Inventory114586767262625
Prepaid expense735    
Assets held-for-sale, not part of disposal group   147  
Other current assets221    
Other undisclosed current assets1352416145412
Total current assets:1,142222193331225241275
Noncurrent Assets
Operating lease, right-of-use asset10192
Property, plant and equipment110807462515349
Long-term investments and receivables      3
Unbilled change orders, amount expected to be collected after one year   3
Intangible assets, net (including goodwill), including:45948551220428113123
Goodwill337337337337848181
Intangible assets, net (excluding goodwill)122148175204283242
Other undisclosed intangible assets, net (including goodwill)   (337)(84)  
Regulated entity, other noncurrent assets   7   
Deferred income tax assets45 
Other noncurrent assets14752115
Deferred tax assets, net22    
Other undisclosed noncurrent assets 25 33084 (3)
Total noncurrent assets:729689613604163166176
TOTAL ASSETS:1,871911806935388407452
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities249454443261822
Accounts payable8627252716912
Accrued liabilities      1
Employee-related liabilities3517191610108
Taxes payable1281     
Debt02054    
Deferred rent credit  1
Business combination, contingent consideration, liability6646311
Deferred revenue and credits  46
Other liabilities32151313578
Other undisclosed current liabilities5040446601(0)
Total current liabilities:337126160128343136
Noncurrent Liabilities
Long-term debt and lease obligation10598 227148147147
Long-term debt, excluding current maturities   227144143142
Finance lease, liability44
Capital lease obligations  445
Operating lease, liability10193
Liabilities, other than long-term debt2723272761025
Deferred revenue and credits2224
Accounts payable and accrued liabilities    111
Deferred rent credit  3
Deferred tax liabilities, net 00215
Other liabilities2112107000
Business combination, contingent consideration, liability6111518245
Total noncurrent liabilities:13212027254154157172
Total liabilities:469246187383188188208
Stockholders' equity
Stockholders' equity attributable to parent1,333560426227201219245
Common stock0000000
Additional paid in capital388426364239205209229
Accumulated other comprehensive loss(0)(0)(0) (0)(0)(0)
Retained earnings (accumulated deficit)94513562(12)(4)1016
Total stockholders' equity:1,333560426227201219245
Other undisclosed liabilities and equity70105194325  (2)
TOTAL LIABILITIES AND EQUITY:1,871911806935388407452

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues1,662535522278192196183
Revenue, net284198201189
Cost of revenue(313)(214)(207)(125)(82)(81)(76)
Cost of goods and services sold(313)(214)(207)(125)(73)(72)(76)
Other undisclosed gross profit   4   
Gross profit:1,349321316156109116106
Operating expenses(312)(249)(237)(161)(114)(113)(119)
Other undisclosed operating income23211815  4
Operating income (loss):1,060939610(4)3(9)
Nonoperating expense
(Other Nonoperating expense)
(20)(16)(33)    
Interest and debt expense(1)(0)(1)(0)0(11) 
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes101(17)(12)(1)(2)
Income (loss) from continuing operations before income taxes:1,0407763(8)(16)(9)(11)
Income tax expense (benefit)(230)(4)11(0)234
Net income (loss) available to common stockholders, basic:8107374(8)(14)(6)(7)
Dilutive securities, effect on basic earnings per share025    
Net income (loss) available to common stockholders, diluted:8117579(8)(14)(6)(7)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):8107374(8)(14)(6)(7)
Comprehensive income (loss):8107374(8)(14)(6)(7)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)(0)0(0)(0)(0)
Comprehensive income (loss), net of tax, attributable to parent:8107374(8)(14)(6)(7)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: